Curcumin-containing polymer and its application in promoting burn healing

Slow-release hydrogel dressings are solved by loading curcumin and magnesium ions with hybrid powder carriers of ε-poly-L-lysine and gamma-polyglutamate, which forms curcumin and magnesium ions, which solves the toxicity of dressings in traditional burn treatments. and the problem of limited efficacy has achieved effective healing of burn wounds and pain relief.

CN115737838BActive Publication Date: 2024-12-03SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202211417513.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-11
Publication Date
2024-12-03
Estimated Expiration
2042-11-11

AI Technical Summary

Technical Problem

Among the existing burn treatment methods, traditional silver ion dressings are toxic to the human body, and drug treatment leads to flora disorders and health problems. It is difficult to effectively close severe burn wounds by drug treatment alone, and traditional dressings cannot protect bioactive drugs for a long time, resulting in limited efficacy.

Method used

Using hybrid powder mixed with ε-poly-L-lysine and γ-polyglutamic acid as carrier, Cur-MOF with curcumin and magnesium ions is loaded to form a hydrogel with slow release and high morphological plasticity. Dressing, used for burn wound treatment.

Benefits of technology

The dressing slowly releases curcumin and magnesium ions, improves biocompatibility and stability, promotes burn healing, relieves pain, prevents infection, and implements adhesive action in and out of the body, successfully closes wounds, reduces pain and scar formation .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115737838B_ABST
    Figure CN115737838B_ABST
Patent Text Reader

Abstract

A curcumin-containing polymer includes a composition of ε-poly-L-lysine and γ-polyglutamic acid as a carrier, and a bioactive Cur-MOF is loaded therein to form Cur-MOF@γ-PGA / ε-PLL. It has been verified that the Cur-MOF@γ-PGA / ε-PLL of the present invention has achieved an adhesive effect both in vivo and in vitro, and successfully closed the wound, and released Cur and Mg 2+ The curative effect of accelerating the healing of burn wounds jointly promotes cell proliferation and the phenotypic polarization of M2 macrophages. Therefore, Cur-MOF@γ-PGA / ε-PLL can be used as a phase-changing hydrogel dressing, which is a powder before use and transforms into a hydrogel after acting on the ablated wound, promoting the healing of clinical burns.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a medical device made of biological material, in particular to a powder which takes curcumin as an active ingredient and is supplemented with a polymer and is used as a dressing to promote the healing of burn wounds. Background Art

[0002] Burns are one of the most common traumas worldwide. Shortening the healing time of deep burn wounds is a challenging clinical problem, which is closely related to reducing burn mortality and preventing scar formation. Burn wounds can be divided into three zones: coagulative necrosis zone (the most serious damage in the middle); ischemic zone (characterized by reduced perfusion, but with the possibility of rescue); hyperemic zone (the outermost layer of the wound is characterized by increased inflammatory vasodilation). The ischemic zone caused by oxygen free radicals and inflammation usually constitutes a large part of the initial wound and gradually necrotizes within 48 hours. Infection and pain in burn wounds are the main causes of shock and death.

[0003] Burns are usually painful and inevitably lead to severe infections. In the past, intravenous antibiotics used to treat infections can cause dysbiosis and further serious health problems. Traditional silver ion dressings are toxic to the human body when used over large areas. In addition, burns are usually painful. Therefore, analgesics and opioids have traditionally been used to relieve pain, but their side effects and addiction are inevitable. Turmeric, an herbaceous plant of the ginger family, has been used for centuries to treat skin diseases, infections, stress, and depression. Curcumin (Cur), the active ingredient in turmeric, has been shown to have antitumor, antibacterial, anti-inflammatory, antioxidant, hypertrophic scar inhibition, pain relief, and wound healing effects. Therefore, Cur can be used as a promising antioxidant, antibacterial agent, and drug for controlling injury-related pain, thereby promoting wound healing. However, the clinical application of Cur is limited by its low stability, low water solubility, rapid decomposition, and poor bioavailability. Therefore, further research and application of auxiliary materials should be conducted to improve the stability and biocompatibility of Cur.

[0004] Based on our previous research, we found that the combination of biomolecules and metal ions can provide protection for the biological activity and stability of biomolecules. Therefore, we successfully prepared a gallic acid-based magnesium organic framework (MOF). Therefore, MOF has high thermal stability and biocompatibility, and in addition, it slowly releases Mg 2+ , thereby regulating inflammation and promoting angiogenesis, which ultimately accelerates diabetic wound healing. (Engineered Regeneration 2022, 3(4), 440-452) However, the unique structure of MOFs for protecting bioactive drugs such as Cur remains understudied.

[0005] Although the application of MOFs can protect the bioactivity of drugs, the large amount of exudate from burns still limits the long-term efficacy of biopharmaceuticals. At the same time, due to the necessity of wound closure, drug therapy alone is not enough to cure severe burns. (NatRev Dis Primers 2020, 6(1), 11) Therefore, wound dressings are needed to further protect the bioactivity of Cur and successfully close the wound. The current gold standard for burn coverage is autologous split-thickness skin grafting (STSG), but it is limited by insufficient autologous skin, artificial dressing substitutes with low biocompatibility, and its inability to protect and deliver bioactive drugs. Many previous studies have demonstrated that poly(γ-glutamic acid) (γ-PGA) hydrogels have good biocompatibility, strong water retention, super absorption and drug release properties. However, due to the large amount of wound exudate after burns, the use of γ-PGA hydrogels alone seems to be ineffective for long-term wound closure and drug delivery. Therefore, there is an urgent need to develop novel hydrogel dressings with high morphological plasticity and wet adhesion to adapt to the special wound conditions of burns while slowly releasing well-protected bioactive drugs from different aspects to promote wound healing. Summary of the invention

[0006] One object of the present invention is to provide a polymer containing curcumin, a polymer containing Cur-MOF to accelerate the healing of burn wounds.

[0007] Another object of the present invention is to provide a polymer containing curcumin to achieve slow release of therapeutic Cur-MOF.

[0008] Another object of the present invention is to provide a polymer powder containing curcumin, which can form a hydrogel with good morphological plasticity and excellent adhesive strength, suitable for use in burn wounds.

[0009] Another object of the present invention is to provide a polymer powder containing curcumin, and its use in preparing a medical device for treating burn wounds and promoting healing.

[0010] A curcumin-containing polymer is prepared by using a mixed composition of ε-poly-L-lysine (ε-PLL) and γ-polyglutamic acid (γ-PGA) as a carrier, in which biologically active Cur-MOF is loaded.

[0011] The weight ratio of ε-PLL:γ-PGA is 1:1, and the carrier is made into a powder, which is a hybrid powder composed of γ-PGA and ε-PLL connected by strong ionic bonds.

[0012] The molecular weight distribution of γ-PGA is Mw = 1000-15000 KDa

[0013] ε-PLL molecular weight distribution is Mw = 2000 ~ 5000KDa

[0014] The amount of bioactive Cur-MOF loaded was 2 mg / mL.

[0015] Cur-MOF includes curcumin and magnesium ions. It is made with Cur as the support structure and magnesium ions as the connection points. It is in granular form with a diameter of 2μm±2μm.

[0016] Exemplarily, the curcumin-containing polymer of the present invention is prepared as follows:

[0017] Cur-MOF is dispersed (e.g., by ultrasound) in a γ-PGA aqueous solution (e.g., 10 wt%) or an ε-PLL aqueous solution (e.g., 10 wt%), and then an ε-PLL aqueous solution (e.g., 10 wt%) or a γ-PGA aqueous solution (e.g., 10 wt%) is added and mixed (the volume ratio of the γ-PGA aqueous solution and the ε-PLL aqueous solution is, for example, 1:1). The mixture is immediately immersed in liquid nitrogen for 15 minutes, and then freeze-dried to remove moisture. Finally, the dried solid is ground using a mortar and pestle to obtain a powdered polymer carrier.

[0018] Cur-MOF@γ-PGA / ε-PLL, formed by combining Cur-MOF and polymer carrier, can achieve continuous release of the active ingredient Cur. From the 24th hour, the concentration of Cur-MOF released by Cur-MOF@γ-PGA / ε-PLL was stable at 7μg / mL±0.6μg / mL.

[0019] After the Cur-MOF@γ-PGA / ε-PLL powder provided by the present invention is placed in the wound, it will quickly absorb the wound exudate and transform into a wet and sticky hydrogel with good morphological plasticity and excellent adhesion strength. It has excellent self-healing properties and is conducive to direct application or injection into wounds with complex geometries, which is suitable for special situations of burns.

[0020] At the same time, this multifunctional powder will slowly release therapeutic Cur-MOF. The unique structure of MOF improves the biocompatibility and stability of Cur, while maintaining the effective concentration of its antioxidant, antibacterial, anti-inflammatory and analgesic effects, while promoting the slow and controlled release of Cur. In addition, during the degradation process, Cur-MOF will also slowly release Mg 2+ , which has anti-inflammatory and angiogenesis-promoting effects.

[0021] It was verified that Cur-MOF@γ-PGA / ε-PLL achieved adhesive effects both in vivo and in vitro, and successfully closed wounds, as well as released Cur and Mg 2+The curative effect of accelerating the healing of burn wounds jointly promotes cell proliferation and the phenotypic polarization of M2 macrophages. Therefore, Cur-MOF@γ-PGA / ε-PLL can be used as a phase-changing hydrogel dressing, which is a powder before use and transforms into a hydrogel after acting on the ablated wound, promoting the healing of clinical burns.

[0022] The powdered curcumin-containing polymer of the present invention is made into a medical device for burns, and can form a hydrogel by absorbing wet tissue exudate without adding any cross-linking agent and organic solvent. It has no restrictions on the shape or size of the wound, can not only cover the wound tightly in a complex shape for protection, but also can effectively cover and protect the wound, absorb exudate, promote tissue regeneration, and has antioxidant, anti-inflammatory, analgesic and antibacterial effects, and has great potential in treating burn wounds.

[0023] In addition, peeling off the wound dressing from the wound is laborious and painful (Acs Appl Mater Inter 2018, 10(48), 41076-41088). The Cur-MOF@γ-PGA / ε-PLL provided by the present invention uses a biodegradable material that can be absorbed by the human body to avoid forced peeling of the dressing, thereby alleviating the patient's pain. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 Figure 1 is a diagram of the synthesis and characterization of Cur-MOF; wherein, a is a schematic diagram of the synthesis of Cur-MOF microspheres; b and c are FE-SEM images of Cur-MOF; d, e, f and g are SEM images and elemental mapping results of Cur-MOF; h is an X-ray diffraction (XRD) spectrum of Cur-MOF powder; i is an absorption spectrum of Cur-MOF and curcumin; j is the absorption intensity of Cur-MOF at different concentrations at 428 nm; k is a photo of curcumin and Cur-mof in water and DMSO; l and m are optical photos and concentration curves used to study the stability of Cur and Cur-mof; n is a graph showing the percentage of Cur-MOF released over time from Cur-MOF@γ-PGA / ε-PLL hydrogel in the presence of PBS;

[0025] Figure 2Figure 3 is a diagram of the preparation and performance test results of γ-PGA / ε-PLL hydrogel; a is a schematic diagram of the preparation of γ-PGA / ε-PLL powder and γ-PGA / ε-PLL hydrogel; b is an optical photograph of the synthesis process of hydrogel A; c is a photograph of γ-PGA / ε-PLL hydrogel and Cur-MOF@γ-PGA / ε-PLL hydrogel; d is a photograph of the adhesion and self-healing of the hydrogel; e is a photograph of adhesion to various tissues, including kidney, spleen, liver, heart, lung and skin; f is a photograph of the polymer diffusion in γ-PGA / ε-PLL hydrogel and fluorescence microscope images changing with time; g is a photo of Cur-MOF@γ-PGA / ε-PLL hydrogel during injection, h is a picture of the sticky filaments of Cur-MOF@γ-PGA / ε-PLL observed under a fluorescence microscope; i is a schematic diagram of the mechanical test; j is a lap shear test curve; k is a tensile test curve; l is a peel test curve; m is a graph of the two hydrogels after moisture absorption at different time points (80% humidity chamber, room temperature); n is a statistical analysis result of the swelling rate of the two hydrogels; o is a graph of the degradation rate of the two hydrogels within 24 days;

[0026] Figure 3 Figure 2 shows the in vitro cell activity, migration and cytotoxicity of Cur-MOF@γ-PGA / ε-PLL; a is a fluorescence microscopy image of double staining of live / dead cells of fibroblasts after co-culture with different materials for 48 hours; b is a cell viability test result diagram of HUVECs co-cultured with different concentrations of Cur-MOF or normal cell culture medium for 48 hours; c is the cell viability of fibroblasts co-cultured with different concentrations of Cur-MOF and different material extracts, or without materials within 48 hours; d is a result diagram of the proliferation and migration ability of fibroblasts after co-culture with different materials (γ-PGA / ε-PLL extract, Cur MOF@γ-PGA / e-PLL extract and Cur MOF solution) or normal cell culture medium (control group); e is the quantification of gap closure rate in different groups, n=3, *p<0.05, **p<0.01, ***p<0.001;

[0027] Figure 4 Figure 2 is the in vitro antioxidant and angiogenic behavior of Cur-MOF@γ-PGA / ε-PLL; a is the ROS analysis result of Raw264.7 cells treated with different methods for 48 hours, and ROS was stained with DCFH-DA (green); b is the statistical analysis result of ROS generation in different treatment groups; c is the cell viability test result of HUVEC co-cultured with Cur-MOF with different concentrations of H2O2 added, or co-cultured with normal cell culture medium; d is the results of the co-culture with γ-PGA / ε-PLL extract, Cur-MOF@γ-PGA / ε-PLL extract, Cur-MOF solution (5 g mL -1) or normal cell culture medium for 6 hours to form tubes; e is the quantitative results of the connection and tube length of each group, n = 3, *p < 0.05, **p < 0.01, ***p < 0.001;

[0028] Figure 5 Figure 2 is an in vivo wound healing assessment diagram of deep burns in mice; a is a representative photograph of burn wounds after different treatments on days 0, 3, 5, 7, 10, 12 and 14, respectively, and the control group is untreated mice; b is a diagram quantifying the wound area rate of each group, n = 4, *p < 0.05, **p < 0.01, ***p < 0.001; c is the H&E and Masson trichrome staining images of burn wounds in different groups on days 7 and 14, and the black arrows indicate the wound edge;

[0029] Figure 6 Figure 2 is the in vivo study result of the cell proliferation and angiogenesis efficacy of Cur-MOF@γ-PGA / ε-PLL; a is a representative image of anti-CD31 (green) and anti-ki67 (red) immunofluorescence staining of different groups on the 7th day, and the cell nucleus was stained with DAPI (blue); b is a representative image of anti-CD31 (green) and anti-ki67 (red) immunofluorescence staining of different groups on the 14th day, and the cell nucleus was stained with DAPI (blue); c is a quantitative result of the capillary density of wound tissues in different groups; d is a quantitative cell proliferation rate diagram of wound tissues in different groups, n=3, *p<0.05, **p<0.01, ***p<0.001;

[0030] Figure 7 Figure 2 shows the in vivo study results of the immunomodulatory effect of Cur-MOF@γ-PGA / ε-PLL cell morphology changes; a is a representative image of double staining of CD68 and CD206 in wound tissues of different treatment groups, using immunofluorescence staining of CD68 (red) and CD206 (green) for M2 polarization, and cell nuclei stained with DAPI (blue); b is the quantification of the number of CD68+ and CD206+ cells in each area (mm -2 ); c is immunofluorescence staining of M1 polarization with CD68 (red) and iNOS (green), and cell nuclei were stained with DAPI (blue). Representative images of double staining of CD68 and iNOS in wound tissues of different treatment groups; d is quantification of the number of CD68+iNOS+ cells in each area (mm -2 ), n=3, *p<0.05, **p<0.01; e is the quantification result of MGS score; f is the quantification of mouse body weight change, n=4, *p<0.05, **p<0.01, ***p<0.001. DETAILED DESCRIPTION

[0031] The technical solution of the present invention is described in detail below with reference to the accompanying drawings. The embodiments of the present invention are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that the technical solution of the invention can be modified or replaced by equivalents without departing from the spirit and scope of the technical solution of the present invention, which should be included in the scope of the claims of the present invention.

[0032] The sources of the main materials used in the following embodiments of the present invention are as follows:

[0033] γ-PGA (Mw = 1000-15000 KDa) was purchased from Cetex Biotechnology Co., Ltd. (China).

[0034] ε-PLL (Mw = 2000-5000 KDa) was purchased from Aladdin (China).

[0035] Curcumin purchased from Macklin (China) had a purity of 98%.

[0036] High-glucose DMEM cell culture medium and fetal bovine serum (FBS) were purchased from Gibco (UK).

[0037] Cell lines including fibroblasts, HUVECs and Raw264.7 cells were cultured with complete medium (high glucose DMEM cell culture medium containing 10% FBS and 1% penicillin-streptomycin) in an incubator (37°C, 5% CO2).

[0038] The various test methods used in the following examples of the present invention are specifically described as follows:

[0039] 1) Characterization of Cur-MOF and Cur-MOF@γ-PGA / ε-PLL

[0040] Cur-MOF was dissolved in DMSO with a series of concentrations of 10 μg / mL to 100 μg / mL, and its absorbance at 428 nm was measured using a microplate reader (SpectraMAX iD3, Molecular Devices. LLC., USA). To obtain a standard curve. Curcumin was measured in the same way at 440 nm to obtain a standard curve. The concentrations of curcumin and Cur-MOF in the solution were calculated using the standard curve.

[0041] 2) Cur-MOF stability test

[0042] Curcumin and Cur-MOF powders were dissolved in DMSO and placed at room temperature under sunlight. 100 μl of the solution was taken every 24 hours, measured with a microplate reader, the concentration was calculated, and photographed for record.

[0043] 3) Tensile test

[0044] The adhesive hydrogel was directly applied to a mechanical testing instrument (GT-TCS-2000 universal material testing machine) with a circular metal contact surface of 4 cm in diameter and connected end-to-end, and the maximum stress of the bonded joint before failure was recorded.

[0045] 4) Peel test

[0046] To evaluate the peel adhesion strength, a 90° peel test was used. The hydrogel samples were fixed with a cloth foil to obtain the original peel adhesion strength and prevent it from extending in the peeling direction.

[0047] 5) Lap shear test

[0048] The adhesive hydrogel was applied to a contact area of ​​5 cm 2 The specimens were placed on glass slides, connected in lap shear mode, and subjected to tensile mechanical tests in lap shear mode. All mechanical tests were performed at room temperature. Three specimens were tested under each condition to ensure the reliability of the data.

[0049] 6) Drug release curves of Cur-MOF and Cur-MOF@γ-PGA / ε-PLL

[0050] Briefly, 40 mg of Cur MOF@γ-PGA / ε-PLL powder was immersed in 5 mL of PBS at 37 °C, and 100 μL of PBS was collected at predetermined time intervals. The same weight of Cur-MOF power dialysis membrane (500 Da) was set as the control group. To measure the amount of released Cur MOF, the absorbance of the extract at 280 nm was measured using a microplate reader.

[0051] 7) Expansion test

[0052] γ-PGA / ε-PLL and Cu-MOOF@γ-PGA / E-PLL powders were immersed in PBS at room temperature, respectively. At predetermined time intervals, the hydrogels were weighed after removing PBS and immersed in PBS again. The hydrogel weight was recorded each time. The swelling ratio was calculated as follows:

[0053] Expansion rate = m / m0 × 100%

[0054] where m and m0 are the weights of the expanded sample and the initial sample, respectively.

[0055] 8) Hygroscopicity test

[0056] The dried Cur-MOF@γ-PGA / ε-PLL powder was placed in a sealed jar at room temperature (30°C) and 80% humidity. The powder was weighed with an electronic scale every 10 minutes to record the changes in the hygroscopicity of the powder.

[0057] 9) Degradation rate test

[0058] γ-PGA / ε-PLL and Cu-MOOF@γ-PGA / E-PLL powders were immersed in PBS and placed in a 37°C, 5% CO2 incubator. At predetermined time intervals, they were taken out and freeze-dried, then weighed and recorded. The degradation rate was calculated as follows:

[0059] Degradation rate = (W-W1) / W×100%

[0060] Where W1 and W are the weights of the immersed sample and the initial sample, respectively.

[0061] 10) Cytotoxicity assay

[0062] Cur-MOF CCK-8 analysis: HUVECs were seeded in 96-well plates with 5000 cells per well and maintained in DMEM medium containing 10% FBS. After starving HUVECs with 100 μL high-glucose DMEM for 12 hours, they were treated with different concentrations of Cur MOF (5, 15, 30, 40, 50, 60, 80, and 120 μg mL-1) and only contained complete medium as a control group for 48 hours. Each group had three parallels. After 48 hours, complete medium containing 10% CCK-8 solution was added to each well to interact with living cells. Then, the cells were placed in an incubator for 1 hour, and the 96-well plate was analyzed with a microplate reader (SpectraMAX iD3, Molecular Devices. LLC., USA).

[0063] CCk-8 analysis of different materials: γ-PGA / ε-PLL and Cur-MOF@γ-PGA / ε-PLL powders were immersed in 5 mL PBS for three days to obtain extracts. Fibroblasts were seeded into 96-well plates at a rate of 5000 cells per well and divided into four groups, namely the control group, the γ-PGA / ε-PLL extract group and the Cu-MOOF@γ-PGA / ε-PLL extract group, and the last group was divided into different concentrations of Cur-MOF (5, 10, 15, 20 and 25 μg / mL) for 48 hours, and the technical detection process was the same as above.

[0064] 11) Live / dead cell double staining

[0065] Fibroblasts were cultured at 60 × 10 4Cells were seeded in 6-well plates at a rate of 10 cells / well. The cells were divided into five groups and co-cultured with γ-PGA / ε-PLL, Cu-MOOF@γ-PGA / ε-PLL and different concentrations of Cur-MOF solution (dissolved in complete medium) (10 and 20 μg / mL) or no material for 48 hours. Calcein AM / PI analysis (Yeasen, Shanghai) was performed according to the manufacturer's protocol. The culture medium was removed and 300 μl of the staining test was added to each well. After removing the supernatant, the 6-well plate was placed in an incubator for 15 minutes. The cells were imaged using a fluorescence microscope.

[0066] 12) In vitro migration analysis.

[0067] Fibroblasts were seeded in 6-well plates and cultured in high-glucose DMEM medium supplemented with 10% FBS. When the cell density in the culture dish reached 90%, a straight line was drawn in the center of the well of the six-well plate with a sterile 200 μL pipette tip, and then washed with PBS to remove the detached cells. The cells were divided into five groups and co-cultured with γ-PGA / ε-PLL, Cur-MOF@γ-PGA / ε-PLL and Cur-MOF solutions (5μg / mL and 10μg / mL) or normal cell culture medium. Microscopic images were taken at 0, 6, 12, and 24 hours after treatment.

[0068] 13) Tube analysis

[0069] First, according to the manufacturer's protocol, 50 μL of growth factor-reduced Matrigel (BD Biosciences, USA) was added to each well of a 96-well plate and then placed in an incubator for 30 minutes until solidified. 4 Cells were seeded on solidified Matrigel matrix and cultured in serum-free DMEM medium with 10 μg / mL Cur-MOF solution, γ-PGA / ε-PLL extract, Cur-MOF@γ-PGA / ε-PLL extract or normal cell culture medium (control). Representative images of each group were taken at the sixth hour.

[0070] 14) In vitro antioxidant test

[0071] The antioxidant effect of different concentrations of Cur-MOF was evaluated by the protective effect on cells in a high H2O2 concentration environment. HUVEC (5000 cells per well) were seeded into 96-well plates. After 24 hours of culture under typical conditions, the cells were exposed to 300 μM H2O2 and cultured for 30 minutes without treatment or with different concentrations of Cur-MOF (15, 30, 40, 50, 60, 80 and 120 μg / mL). The group that did not receive hydrogen peroxide or treatment was set as the control group. Using the CCK-8 kit, the cell activity of HUVEC after different antioxidant treatments was determined in the same manner as previously described.

[0072] 15) In vitro anti-inflammatory test

[0073] The anti-inflammatory effect of Cur-MOF@γ-PGA / ε-PLL was evaluated on LPS-induced inflammation-positive RAW 264.7 cells. RAW 264.7 cells (70×10 4 cells) were seeded into six-well plates. After culturing for 24 h under typical conditions, the cells were exposed to 10 μg / mL LPS and cultured for 48 h without treatment or with extracts of γ-PGA / ε-PLL, Cur-MOF@γ-PGA / ε-PLL, and Cur-MOF solutions (10 and 20 μg mL-1). The group without LPS or treatment was set as the control group. Raw264.7 cells were stained using a ROS detection kit (Beyotime, China) according to the manufacturer's protocol. The stained cells were first photographed using a fluorescence microscope and then collected and analyzed using a flow cytometer (Beckman Coulter, USA).

[0074] 16) Establishment of deep burn wound model in vivo and evaluation of wound healing

[0075] Mouse burn model: A deep burn model was established using 6-week-old C57BL / 6 mice. The hair was removed with barium sulfide, and the mice were anesthetized after an interval of 24 hours. A cylindrical copper rod with a bottom diameter of 1 cm was connected to a constant temperature soldering iron, the soldering iron temperature was adjusted to 120°C, and the bottom temperature was checked with a thermometer. When the weight was 300 mg and the duration was 5 seconds, a circular burn wound with a diameter of 1 cm was formed on the back of the mouse. At an interval of 24 hours, the eschar formed on the scald wound on the back of the mouse was quickly removed, forming a circular wound with a diameter of 1 cm. (Mil Med Res 2022, 9(1), 42)

[0076] Subsequently, 44 mice were randomly divided into different treatments (control group, Cur-MOF solution (20 μg / mL) group, γ-PGA / ε-PLL powder group, and Cur-MOF@γ-PGA / ε-PLL powder group). Mice were housed in individual cages with ample food and water. Images of the wound area were taken on days 0, 1, 3, 5, 7, 10, 12, and 14 after burn injury.

[0077] 17) Histology and immunohistochemistry staining

[0078] On the third, seventh and fourteenth day after treatment, mice were killed with an overdose of 4% chloral. Skin tissue from the wound area was first removed and immersed in 4% paraformaldehyde for more than 24 hours. After dehydration, the samples were embedded in wax blocks and cut into 5 μm thick sections for subsequent staining. To detect the wound healing process, hematoxylin and eosin (H&E), Masson's trichrome staining and immunofluorescence staining were applied here, using anti-CD31 (1:500) and anti-ki67 (1:500). To test macrophage polarization, antibodies against CD68, CD206 and iNOS were used here.

[0079] 18) Statistical analysis

[0080] All quantitative data are presented as mean ± standard deviation. Unpaired Student's t-test was used for two groups, and one-way ANOVA with Tukey's post hoc test was used for more than two groups. Statistical analysis was performed using SPSS (Statistical Package for Social Sciences) 26.0, and two-sided P < 0.05 was considered statistically significant. GraphPad Prism 8.0 was used for graphics. Image J software (NIH, Bethesda, MD, USA) was used for image analysis and statistics.

[0081] Example 1 Synthesis and characterization of Cur-MOF

[0082] 1) Preparation of Cur-MOF

[0083] First, Cur-MOF was synthesized using a solvothermal method (Acs Nano 2021, 15 (11), 17842-17853), but the previous method was also improved. 8g of curcumin and 500mL of deionized water were mixed under magnetic stirring for 10 minutes. A 10M NaOH aqueous solution was then added to adjust the pH to 12. 10g of MgCl2 was added and magnetically stirred for 10 minutes, and then the mixed solution was heated at 120°C in a muffle furnace (Sxi-8-10, Xinhan Instrument Equipment Co., Ltd., Zhengzhou, China) for 24 hours. The reddish-brown solid was separated in a centrifuge (10000rpm, 15min, 4°C), washed twice with ethanol, and then washed twice with deionized water.

[0084] 2) Preparation of γ-PGA / ε-PLL powder

[0085] A 10 wt% γ-PGA and 10 wt% ε-PLL aqueous solution was mixed in a volume ratio of 1:1. The mixture was immediately immersed in liquid nitrogen for about 15 minutes without pouring out any liquid, and freeze-dried to remove moisture. Finally, the dried solid was ground using a mortar and pestle to obtain γ-PGA / ε-PLL powder.

[0086] 3) Preparation of Cur-MOF@γ-PGA / ε-PLL powder

[0087] Cur-MOF powder was dispersed in a 10 wt% ε-PLL aqueous solution by ultrasonication, and then an equal volume of 10 wt% γ-PGA aqueous solution was mixed. The mixture was immediately immersed in liquid nitrogen for about 15 minutes without pouring out any liquid, and freeze-dried to remove moisture. Finally, the dried solid was ground into orange Cur-MOF@γ-PGA / ε-PLL powder using a mortar and pestle.

[0088] Cur-MOF is a biocompatible porous material with magnesium ions as the connection points and curcumin as the skeleton ( Figure 1 a). Scanning electron microscopy (SEM) images show that Cur-MOF has a uniform spherical structure with a diameter of 2-4 μm ( Figure 1 b and 1c). The composition of Cur-MOF was confirmed by elemental mapping using bright-field scanning electron microscopy. The results showed that carbon (C), magnesium, and oxygen (O) were uniformly distributed in Cur-MOF ( Figure 1 dg). X-ray diffraction (XRD) of Cur-MOF powder produced characteristic peaks of crystal formation ( Figure 1 h), which further demonstrated the successful synthesis of Cur-MOF.

[0089] In addition, curcumin and Cur-MOF showed characteristic absorption peaks at 440 nm and 428 nm, respectively ( Figure 1 i and 1j). To test whether Cur-MOF improves the bioavailability of curcumin, curcumin and Cur-MOF were dissolved in water and dimethyl sulfoxide, respectively, and the results showed that curcumin was insoluble in water but soluble in dimethyl sulfoxide, while Cur-MOF was soluble in both water and dimethyl sulfoxide ( Figure 1 k). To study the different stabilities of Cur and Cur-MOF, they were exposed to sunlight (at room temperature) for 7 days. Figure 1As shown in Figure 1, a clear color change in the Cur solution is shown, indicating its low stability. The residual concentrations of Cur and Cur-MOF were quantified on the 7th day, showing that curcumin decreased significantly, while Cur-MOF decreased slowly (Figure 2m). In order to test whether the fabrication of Cur-MOF@γ-PGA / ε-PLL can prolong the release of Cur-MOF, Cur-MOF@γ-PGA / ε-PLL was placed in PBS to detect the Cur-MOF concentration at the corresponding time point, and the sustained release curve was obtained ( Figure 1 n).

[0090] γ-PGA is a positively charged acidic macromolecule, while ε-PLL is a negatively charged basic polymer. Anions and cations attract each other and are tightly bound by physical interactions between ions, resulting in an adhesive hydrogel ( Figure 2 a). The resulting adhesive hydrogel was freeze-dried and ground into powder to obtain white γ-PGA / ε-PLL powder ( Figure 2 b). After freeze drying, the microstructure of the adhesive was observed under a scanning electron microscope (SEM), and both γ-PGA / ε-PLL and Cur-MOF@γ-PGA / ε-PLL showed a porous structure. Meanwhile, the particle size of the ground powder was observed by SEM in the range of 0.02–0.15 mm.

[0091] The resulting γ-PGA / ε-PLL powder can be quickly converted into a hydrogel by simply adding water or phosphate buffered saline (PBS). In addition, red dye was added to the γ-PGA / ε-PLL powder to test the gelation time of the γ-PGA / ε-PLL powder. The γ-PGA / ε-PLL powder quickly absorbed water and swelled, connecting to each other to form a large hydrogel. At the same time, both the γ-PGA / E-PLL hydrogel and Cur-MOF@γ-PGA / ε-PLL could be instantly healed ( Figure 2 d). In addition, γ-PGA / ε-PLL powder can adhere to different wet tissues, such as heart, lung, pancreas, kidney, liver, skin, etc. ( Figure 2 e). In order to further study the self-gelling property of γ-PGA / ε-PLL powder, fluorescent Cur-MOF was added to the γ-PGA / ε-PLL powder. Therefore, the powder changes during the hydrogel hydration process can be observed under a fluorescence microscope ( Figure 2 f).

[0092] This thixotropic behavior demonstrates the excellent self-healing properties of the hydrogel and facilitates its direct application or injection into wounds with complex geometries ( Figure 2 g). γ-PGA / ε-PLL retains the physical properties of PGA fibrils and adhering materials but is insoluble in water, while Cur MOF inherits the green fluorescence properties of curcumin ( Figure 2h). γ-PGA / ε-PLL adhesive hydrogels adhere to various surfaces such as glass, plastic, metal, and oily biscuits.

[0093] Based on the SEM images, the corresponding pore sizes of the two hydrogels were also quantified. In addition, the swelling ratios of the freeze-dried two hydrogel samples were slightly lower than that of γ-PGA / ε-PLL ( Figure 2 n). The results showed that the addition of Cur-MOF promoted a tighter connection between the two macromolecules. It can be observed that the two hydrogels continued to absorb water and swell in the PBS solution without dissolving, and the dividing line was clearly observed in the solution. In the first 6 minutes, the hydrogels rapidly absorbed water and then stabilized, with the expansion rates measured at 20 minutes being approximately 326% and 338%. The two hydrogels were placed in a closed jar with a humidity of 80%, and the weight of the hydrogels was recorded. The results show that the hygroscopicity of Cur MOF@γ-PGA / ε-PLL is slightly higher than that of γ-PGA / E-PLL, and it tends to be stable at 220min ( Figure 2 m). The excellent hygroscopicity of the viscous hydrogel can provide a favorable environment for wound healing by absorbing excess tissue exudate produced on the wound surface. In addition, the degradation rate of the hydrogel was studied, and it was found that Cur-MOF@γ-PGA / ε-PLL was slightly more stable than γ-PGA / ε-PLL. Obviously, Cur-MOF strengthened the tight connection of the gel. The degradation rates of the two hydrogels slowed down on the fifth day, and were 48.55% and 33.40% on the 20th day, respectively ( Figure 2 o). The structural stability of the hydrogel enables it to maintain protection and support for the wound during treatment. To achieve effective treatment, prolonged and stable release of Cur-MOF at the wound site is advantageous. In sharp contrast to Cur-MOF, Cur-MOF@γ-PGA / ε-PLL exhibited stable and sustained release behavior without significant burst release. Starting from the 24th hour, the concentration of Cur-MOF released from Cur-MOF@γ-PGA / ε-PLL stabilized at around 7 μg / ml ( Figure 1 n). To characterize the adhesion of the hydrogel adhesive, the macroscopic mechanical properties of the adhesive were measured. Lap shear, tensile, and peel tests were performed on γ-PGA, ε-PLL, and γ-PGA / ε-PLL for comparison ( Figure 2 i). The results showed that the combination of γ-PGA and ε-PLL significantly improved the mechanical properties of γ-PGA / ε-PLL. The lap shear strength of γ-PGA / ε-PLL increased by 1.50 and 1.39 times compared with PGA and PLL, respectively ( Figure 2j). Meanwhile, in terms of tensile and peel strength, γ-PGA and ε-PLL were compared with γ-PGA / ε-PLL, which increased by 3.93 times and 75.1 times, 2.85 times and 16.13 times, respectively ( Figure 2 kl)

[0094] Example 2 In vitro biocompatibility of Cur-MOF and Cur-MOF@γ-PGA / ε-PLL hydrogels

[0095] We performed CCK-8 assay to investigate the effect of different concentrations of Cur-MOF on cell viability and the results showed that when the concentration reached 25 μg mL -1 When the concentration of CurMOF- was 5 μg mL -1 The cell survival rate was significantly higher than that of the control group. The same experiment was performed on γ-PGA / ε-PLL and Cur MOF@γ-PGA / E-PLL.

[0096] It can be seen that γ-PGA / ε-PLL and Cur-MOF@γ-PGA / ε-PLL extracts did not show cytotoxicity, and the 5-20 μg mL -1 The high concentration of Cur-MOF showed no cytotoxic effect, and low dose of Cur-MOF significantly promoted fibroblast proliferation within 48 hours ( Figure 3 bc).

[0097] To further demonstrate the biocompatibility of the material, the -1 Live / dead double staining experiments were performed on γ-PGA / ε-PLL, Cur-MOF@γ-PGA / ε-PLL, and Cur-MOF solutions, and similar results were obtained ( Figure 3 a).

[0098] Example 3 Cur-MOF and Cur-MOF@γ-PGA / ε-PLL hydrogels enhance cell proliferation, migration and angiogenesis in vitro

[0099] The scratch test was performed to evaluate the performance of γ-PGA / ε-PLL, Cur-MOF@γ-PGA / ε-PLL and Cur-MOF solutions (concentrations of 5 μg ml -1 and 10 μg ml -1) on cell proliferation and migration. The results showed that the effects of the other treatment groups on cell migration and proliferation were enhanced compared with the untreated group. The enhancement was most obvious in the Cur-MOF@γ-PGA / ε-PLL group, and quantitative analysis showed that the residual area after 24 hours was 2.86 times smaller than that in the control group. Compared with the treatment groups using different concentrations of Cur MOF solution, 5 μg ml -1 The effect of the group on cells was slightly stronger, which is similar to the conclusion of the previous CCK8 experiment ( Figure 3 de). In addition, tube formation experiments were performed ( Figure 4 d). HUVECs were incubated with DMEM (control group), Cur-MOF solution, or γ-PGA / ε-PLL or Cur-MOF@γ-PGA / ε-PLL extracts for 6 h. Figure 4 e Quantification and display of the length of the junctions and tubes in different groups. Compared with the control group, the number of junctions and tube lengths in all three treatment groups increased significantly, especially in the Cur-MOF@γ-PGA / ε-PLL group.

[0100] Example 4 In vitro antioxidant and anti-inflammatory activities of Cur-MOF and Cur-MOF@γ-PGA / ε-PLL hydrogels

[0101] The CCK8 assay was used to assess cell viability after treatment with different concentrations of Cur in the presence of hydrogen peroxide to demonstrate the antioxidant activity of Cur-MOF. The cytotoxicity of Cur-MOF was previously assessed using HUVECs, and cell viability was significantly correlated with concentrations above 25 μg ml -1 Interestingly, in the presence of hydrogen peroxide, even at concentrations as high as 120 μg ml -1 , cell survival also increased with increasing Cur-MOF concentration ( Figure 4 c). Therefore, it was demonstrated that Cur-MOF possessed antioxidant activity, which increased with increasing concentration.

[0102] In order to investigate the ability of Cur-MOF@γ-PGA / ε-PLL to scavenge reactive oxygen species in vitro, lipopolysaccharide (LPS) was first used to induce macrophages to produce oxidative free radicals. Next, 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) was used as a ROS probe to evaluate the ROS level during incubation by green fluorescence intensity. The results showed that the fluorescence intensity of cells treated with γ-PGA / ε-PLL was significantly lower than that of cells treated with LPS. At the same time, the fluorescence intensity of the Cur-MOF@γ-PGA / ε-PLL group was also significantly lower than that of the LPS group, indicating that Cur-MOF@γ-PGA / E-PLL has free radical scavenging ability. Contrary to the expected results, the fluorescence intensity of cells treated with the Cur-MOF group was very high. Compared with the different concentrations of the Cur-MOF solution group, the higher the concentration of the Cur-MOF solution group, the higher the fluorescence intensity ( Figure 4 a and Figure 4 b). Similar to vitamin C, curcumin is a powerful reducing agent with antioxidant and anti-oxidant properties. The effect of curcumin in promoting the production of reactive oxygen species is closely related to its anti-tumor and anti-scarring effects. Flow cytometry reported similar results. Studies have shown that the anti-inflammatory and proliferative activities of curcumin are independent of its ability to regulate the state of reactive oxygen species.

[0103] Example 5 Cur-MOF@γ-PGA / ε-PLL hydrogel promotes deep burn wound healing and angiogenesis in vivo

[0104] A circular third-degree burn model with a diameter of 1 cm was established on the back of mice. The mouse skin was treated every 24 hours after the hair removal treatment to exclude the chemical loss of the hair removal cream applied to the mouse skin. Due to the continuous damage caused by the thermal effect, the wound continued to deepen after the burn until 24 hours later, when the wound stopped progressing and became stable. At this time, the eschar of the burn was removed, and the powder of the treatment group was evenly sprayed on the wound with a powder sprayer. Wait 10 minutes to allow the powder to absorb moisture from the wound and form a gel to seal the wound. Compared with the other groups, the wound of the Cur-MOF@γ-PGA / ε-PLL group was almost completely healed on the 12th day ( Figure 5 a). The Cur-MOF and γ-PGA / ε-PLL groups also healed on day 14, while the control group still had smaller wounds.

[0105] The percentage of residual wound area was statistically compared ( Figure 5 b) These results indicate that Cur-MOF@γ-PGA / ε-PLL has synergistic effects of promoting angiogenesis, promoting cell proliferation, anti-oxidation, anti-inflammation, and antibacterial properties, thus having an effective wound healing effect.

[0106] Example 6 Cur-MOF@γ-PGA / ε-PLL hydrogel promotes tissue regeneration and angiogenesis in vivo

[0107] Wound bed, granulation, and epithelialization processes were visualized by hematoxylin and eosin (H&E) staining, while collagen deposition and angiogenesis were visualized by Masson's trichrome staining ( Figure 5 c). On day 7, epithelial coverage in the Cur-MOF@γ-PGA / ε-PLL group was already higher than that in the control group. On day 14, macroscopic observations of wound healing were consistent with the results of the Cur-MOF@γ-PGA / ε-PLL and Cur-MOF groups. The epithelial cells in the Cur-MOF and Cur-MOF@γ-PGA / ε-PLL groups were completely covered, and the epithelial cells in the control group and the γ-PGA / ε-PLL groups were defective, but the epithelial coverage in the PP group was higher than that in the control group. The wound bed treated with the Cur-MOF@γ-PGA / ε-PLL group showed more collagen formation than the other groups, indicating better wound closure.

[0108] Immunofluorescence staining was used to assess in vivo tissue regeneration. CD31 and KI67 were used to mark capillaries and proliferating cells in the regenerating tissue, respectively. Figure 6 a and Figure 6 b). Capillary density ( Figure 6 c) and the number of regenerative cells ( Figure 6 d) was quantified. The results showed that on the 7th day of wound healing, the proliferation of the Cur-MOF@γ-PGA / ε-PLL group was significantly better than that of the control group, while there was a slight difference between the Cur-MOF@γ-PGA / ε-PLL group and the Cur-MOF group. Further comparison on the 14th day revealed significant differences between the Cur-MOF@γ-PGA / ε-PLL group and the other groups. The density of proliferating capillaries in the Cur-MOF@γ-PGA / ε-PLL group was 2.86, 1.57, and 1.70 times higher than that of the control group, γ-PGA / ε-PLL group, and Cur-MOF group, respectively.

[0109] Example 7 Cur-MOF@γ-PGA / ε-PLL hydrogel induces M2 repolarization in vivo

[0110] Macrophages have important regulatory activities in many inflammatory cells. In the early stages of wound healing, the timely and appropriate transition from the initial inflammatory M1 macrophage morphology to the anti-inflammatory M2 macrophage morphology is essential for reestablishing normal homeostasis. Therefore, on the third day, immunofluorescence staining was performed on wound tissues of the γ-PGA / ε-PLL, Cur-MOF, Cur-MOF@γ-PGA / E-PLL treatment groups and wounds without any treatment (control group). There are macrophage markers (CD68, red), M1 macrophage markers (iNOS, green) and M2 macrophage markers (CD206, green) ( Figure 7 a and Figure 7 c). Quantification of CD68+ and CD206+ cell numbers showed that Cur-MOF@γ-PGA / ε-PLL, Cur-MOF, and γ-PGA / E-PLL treatments increased M2 polarization by 4.43, 2.43, and 1.14 times, respectively, compared with the control group ( Figure 7 b). Meanwhile, quantification of the number of CD68+iNOS+ cells showed that no M1 cells were found in the tissue immunofluorescence staining of Cur MOF and Cur MOF@γ-PGA / ε-PLL groups on the third day. M1 cells were found in both the control group and the γ-PGA / ε-PLL group ( Figure 7 d). This further demonstrates the anti-inflammatory activity of Cur-MOF and Cur-MOF@γ-PGA / ε-PLL, and Cur-MOF@γ-PGA / ε-PLL is superior to Cur-MOF.

[0111] Example 8 Cur MOF and Cur MOF@γ-PGA / ε-PLL hydrogels can effectively relieve pain after burns

[0112] Burns are a very painful experience, and pain relief is particularly important in the treatment of burn wounds. Many studies have shown that curcumin has analgesic effects. Pain affects the diet and metabolism of mice, thereby affecting their weight. Therefore, the weight changes of mice after treatment were recorded, and the pain of mice was assessed using the Mouse Grimace Scale (MGS). The results showed that on the first day after treatment, the weight of mice in the γ-PGA / ε-PLL group and the control group decreased to nearly 9% of their pre-treatment weight, while the weight of mice in the Cur-MOF group and the Cur-MOF@γ-PGA / ε-PLL group did not change significantly. Over the next 14 days, the weight of all four groups continued to increase, with the γ-PGA / ε-PLL group and the control group gaining weight faster. The weights of the four groups gradually approached each other ( Figure 7e). The above results show the pain in the early stage of burns in mice and the analgesic effect of Cur-MOF. MGS evaluation also showed that the pain of mice was severe in the first three days and gradually subsided after the fifth day. On day 2, there was no significant difference between the Cur-MOF group and the Cur-MOF@γ-PGA / ε-PLL group, and the average score of the Cur-MOF group was lower than that of the PP group and the control group. As of day 3, the scores of the Cur-MOF@γ-PGA / ε-PLL group and the Cur-MOF group were significantly different, once again indicating the sustained release of the active ingredients in the Cur-MOF@γ-PGA / ε-PLL group ( Figure 7 f).

Claims

1. A powder of a polymer containing curcumin, characterized in that A composition of ε-poly-L-lysine and γ-polyglutamic acid is used as a carrier, and the bioactive Cur-MOF is loaded therein; The Cur-MOF comprises curcumin and magnesium ions, and is prepared with Cur as a support structure and magnesium ions as connection points, and is in a granular form; The powder of the curcumin-containing polymer is prepared as follows: Disperse Cur-MOF in γ-PGA aqueous solution, then add ε-PLL aqueous solution accordingly, mix, and immediately immerse in liquid nitrogen; or Cur-MOF was dispersed in ε-PLL aqueous solution, and then γ-PGA aqueous solution was added accordingly, mixed, and immediately immersed in liquid nitrogen; After that, freeze-drying is performed to remove moisture; Finally, the dried solids were ground into a powder using a mortar and pestle; The powder formed a hydrogel after absorbing the liquid, and the concentration of released Cur-MOF was stable at 7 μg / ml ± 0.6 μg / ml starting from the 24th hour; The Cur is curcumin.

2. The curcumin-containing polymer powder according to claim 1, characterized in that The weight ratio of ε-PLL:γ-PGA is 1:

1.

3. Use of the curcumin-containing polymer powder according to claim 1 in preparing medical devices for burns.

4. The use according to claim 3, characterized in that The medical device is a powder dressing.

5. A medical device, characterized in that A powder comprising the curcumin-containing polymer according to claim 1 or 2.

Citation Information

Patent Citations

  • Hydrogel based on gamma-polyglutamic acid and epsilon-polylysine cross-linked polymer and preparation method thereof

    CN103656729A